OTHER INFORMATION
+Added: 10.1 Purchase and Sale Agreement, dated January 29, 2021, by and between Krystal Biotech, Inc.
+Added: and Northfield I, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, as filed with the SEC on February 2, 2021).
31.1 Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.
10 unchanged sentences
KRYSTAL BIOTECH, INC.
−Removed: November 6, 2020 By:
+Added: May 10, 2021 By:
President and Chief Executive Officer
+Added: (Principal executive officer)
/s/ Kathryn A.
Chief Accounting Officer
+Added: (Principal financial and accounting officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.